PROTAGONIST THERAPEU

PTGX
Delayed Quote. Delayed  - 12/08 04:00:01 pm
34.04USD +0.65%

Turn to zoom
Prev.34.0400
Open33.6500
High34.4500
Low33.1000
Volume416 112
Latest news
5d ago
6d ago
6d ago
6d ago
Chart PROTAGONIST THERAPEUTICS, INC.
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance37,149,749,4
Spread/Res.-8,2%-31%-31%
Spread/Supp.10%163%94%
Support30,913,017,5
Financials
Sales 2021 23,8 M - -
Net income 2021 -127 M - -
Net cash 2021 248 M - -
P/E ratio 2021 -12,6x
Yield 2021 -
Capitalization 1 625 M 1 625 M -
EV / Sales 2021 57,8x
EV / Sales 2022 54,1x
Nbr of Employees 116
Free-Float 98,8%
Company
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company uses its peptide technology platform to discover and develop peptide-based drugs to address unmet medical needs. Its clinical programs fall under two categories of diseases, which includes hematology and blood...

>> Read more
Sector :
Other Biotechnology & Medical Research
Calendar :
2021-12-11 Presentation
Trading Rating :
Investor Rating :

Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 34,04 $
Average target price 59,00 $
Spread / Average Target 73,3%